C07D 471/04
Ortho-condensed systems
C07D471/04 (Ortho-condensed systems) appears on 18,064 US grants and 22,398 published applications in this corpus.
Search patents in C07D- Granted patents
- 18,064
- Published applications
- 22,398
- Assignees
- 4,598
- Inventors
- 41,736
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 92 | 0 |
| 1977 | 74 | 0 |
| 1978 | 76 | 0 |
| 1979 | 44 | 0 |
| 1980 | 70 | 0 |
| 1981 | 82 | 0 |
| 1982 | 70 | 0 |
| 1983 | 46 | 0 |
| 1984 | 78 | 0 |
| 1985 | 94 | 0 |
| 1986 | 106 | 0 |
| 1987 | 107 | 0 |
| 1988 | 120 | 0 |
| 1989 | 128 | 0 |
| 1990 | 138 | 0 |
| 1991 | 153 | 0 |
| 1992 | 156 | 0 |
| 1993 | 169 | 0 |
| 1994 | 144 | 0 |
| 1995 | 176 | 0 |
| 1996 | 223 | 0 |
| 1997 | 283 | 0 |
| 1998 | 221 | 0 |
| 1999 | 201 | 0 |
| 2000 | 188 | 0 |
| 2001 | 229 | 50 |
| 2002 | 242 | 292 |
| 2003 | 307 | 441 |
| 2004 | 252 | 701 |
| 2005 | 270 | 613 |
| 2006 | 311 | 592 |
| 2007 | 319 | 670 |
| 2008 | 333 | 660 |
| 2009 | 434 | 792 |
| 2010 | 488 | 899 |
| 2011 | 463 | 863 |
| 2012 | 590 | 816 |
| 2013 | 776 | 872 |
| 2014 | 795 | 1011 |
| 2015 | 884 | 997 |
| 2016 | 759 | 1084 |
| 2017 | 917 | 971 |
| 2018 | 835 | 1038 |
| 2019 | 850 | 1088 |
| 2020 | 832 | 1103 |
| 2021 | 730 | 1001 |
| 2022 | 638 | 1109 |
| 2023 | 619 | 1364 |
| 2024 | 664 | 1326 |
| 2025 | 776 | 1165 |
| 2026 | 512 | 880 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Crystalline form of heterocyclic compound as protein kinase inhibitor6 Oct 2026US 12,753,174 B2Hk Inno. N Corporation
- FGFR inhibitor compound and use thereof6 Oct 2026US 12,753,179 B2Shenzhen Kangsu Pharmaceutical Technology Co., Ltd.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Compounds for treating hereditary spastic paraplegia8 Oct 2026US 2026/0306465 A1Children's Medical Center Corporation
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
- 5-ht2a receptor inverse agonist, and preparation method therefor and use thereof8 Oct 2026US 2026/0308142 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
Most cited
By later US patents
- 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use451US 4,689,338 ARiker Laboratories, Inc. · 1987
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines350US 5,389,640 AMinnesota Mining and Manufacturing Company · 1995
- Alkynylamino-nucleotides340US 5,047,519 AE. I. Du Pont de Nemours and Company · 1991
- Olefinic 1H-imidazo(4,5-c)quinolin-4-amines319US 4,929,624 AMinnesota Mining and Manufacturing Company · 1990